Undervalued based on future growth

Ergebnisse

70

12 neu

Companies which can be considered undervalued when accounting for expected future growth (PEG under 0.8)

70 Unternehmen

	Unternehmen	Letzter Preis	7D Rückkehr	1J Rückkehr	Marktkapitalisierung	Analysten Ziel	Bewertung	Wachstum	Div. Rendite	Industrie
	2408	NT$541.00	4.6%	1,059.7%	NT$1.9t	NT$559.83	21.0	49.0%	0.3%	Semiconductors
	2382	NT$333.50	2.0%	25.4%	NT$1.3t	NT$427.84	14.5	18.6%	4.7%	Tech
	6669	NT$6,815.00	7.7%	129.1%	NT$1.3t	NT$8,202.00	21.8	31.7%	1.1%	Tech
	2344	NT$186.00	5.4%	849.0%	NT$837.0b	NT$247.57	20.5	68.3%	0.3%	Semiconductors
	3231	NT$179.50	-0.3%	56.1%	NT$570.8b	NT$266.53	14.3	36.0%	2.1%	Tech
	6770 Neu	NT$69.60	3.4%	333.6%	NT$295.4b	NT$99.72	20.9	35.3%	0%	Semiconductors
	3044	NT$481.00	-0.9%	51.3%	NT$252.8b	NT$685.71	20.6	29.4%	2.6%	Tech
	2337	NT$127.50	4.5%	534.3%	NT$252.4b	NT$175.00	30.2	77.9%	0%	Semiconductors
	3036	NT$193.00	-6.1%	56.9%	NT$245.2b	NT$314.86	10.0	28.9%	4.0%	Tech
	2324 Neu	NT$39.75	3.2%	41.5%	NT$173.2b	NT$37.73	20.5	27.1%	2.8%	Tech
	1802	NT$59.20	2.6%	71.3%	NT$172.2b	NT$63.00	68.7	87.0%	0%	Capital Goods
	1504	NT$73.40	0.4%	7.2%	NT$172.2b	NT$95.86	26.6	33.3%	2.7%	Capital Goods
	3702	NT$101.50	-2.9%	51.5%	NT$170.4b	NT$144.33	8.6	20.7%	3.7%	Tech
	2347	NT$86.80	-0.2%	32.5%	NT$144.8b	NT$105.33	11.9	23.0%	4.8%	Tech
	6442	NT$1,595.00	2.6%	84.0%	NT$124.2b	NT$3,333.00	45.0	84.6%	0.7%	Tech
	3706	NT$91.40	1.4%	-4.7%	NT$121.3b	NT$105.63	16.3	21.5%	3.3%	Tech
	2027	NT$48.65	-3.7%	26.0%	NT$114.4b	NT$56.33	9.6	20.7%	3.1%	Materials
	3026	NT$675.00	-4.9%	694.1%	NT$112.0b	NT$555.00	65.9	94.8%	0.9%	Tech
	1503	NT$212.50	5.5%	13.3%	NT$110.7b	NT$243.50	29.3	42.7%	2.4%	Capital Goods
	2542	NT$47.75	-1.1%	19.7%	NT$100.8b	NT$49.50	11.1	25.3%	8.4%	Real Estate Management and Development
	3324	NT$1,060.00	6.7%	53.0%	NT$98.7b	NT$1,420.20	24.4	30.9%	1.1%	Tech
	8150	NT$90.30	2.7%	267.8%	NT$63.2b	NT$120.00	28.1	36.2%	1.4%	Semiconductors
	6278	NT$206.00	14.4%	91.6%	NT$59.5b	NT$177.00	20.9	50.5%	2.7%	Tech
	6472	NT$439.50	-1.3%	-40.0%	NT$56.0b	NT$579.04	30.8	46.0%	2.3%	Pharmaceuticals & Biotech

Page 1 of 2